VANCOUVER, British Columbia, Jan. 26, 2023 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, is pleased to announce the engagement of Bloom Burton Securities Inc. (“Bloom Burton”) for strategic advisory…

Source

Previous articlePT384 – Vital Psychedelic Conversations
Next articleAdelaide Wilcox King: The Psychedelic Industry as a Catalyst for Reimagining Capitalism and the Purpose-Driven Firm​